Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,027 public trials 268 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Active, Not Recruiting

A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

NCT04557098

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

NCT03399799

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Mount Sinai Medical Center New York, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Durvalumab and Tremelimumab for Pediatric Malignancies

NCT03837899

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +5 more
Locations
  • Research Site Baltimore, Maryland, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New Hyde Park, New York, United States
  • Research Site Oklahoma City, Oklahoma, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

NCT01594723

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +3 more
Locations
  • Highlands Oncology Group - Duplicate 2 Rogers, Arkansas, United States
  • Providence St. Joseph's Medical Center Burbank, California, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
  • Lakeland Regional Cancer Center Lakeland, Florida, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer

NCT02862275

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +9 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Moffitt Cancer Center-International Plaza Tampa, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
View Trial Details

Related conditions